ABSTRACT Hematopoietic stem cells (HSCs) arise first in the third week of human ontogeny inside yolk sac developing blood vessels, and independently, from the wall of the embryonic aorta and vitelline arteries one week later. HSCs produced in the yolk sac and in the embryonic truncal arteries migrate to and transiently colonize the embryonic liver (EL), and thereafter the bone marrow (BM), their permanent site of residence. At the moment, the origin of human HSCs is still controversial; one of the main hypotheses being that they are generated by hemogenic endothelial cells (ECs). To proove definitively the endothelial origin of HSCs that arise within the human embryo, we previously purified ECs from either the yolk sac or the truncal arteries and reported that they were able to produce blood cells in vitro. We then found that some of the HSCs present in the human EL were co-expressing vascular endothelial (VE)-cadherin, an endothelial marker, CD45, a pan-hematopoietic marker, and CD34, a common endothelial and hematopoietic marker, and demonstrated that these HSCs bearing a dual hemato-endothelial phenotype were endowed with remarkably high self renewal and proliferative potentials. Furthermore, a transgenic mouse model based on the VE-cadherin cis-regulating elements that we engineered to trace the fate of the first VE-cadherin expressing cells allowed us to clearly demonstrate that a majority of adult BM HSCs derived from a VE-cadherin ancestor. Altogether our studies strongly suggest that at least a part of both the human and the murine hematopoietic systems arise from an endotheliumlike ancestor.
Introduction
Blood cells are constantly produced in the bone marrow (BM) of adult mammals. This turnover depends on a rare population of cells that display self-renewal and multilineage differentiation potential, the hematopoietic stem cells (HSCs). It is generally accepted that HSCs are generated during embryonic development to sequentially colonize the embryonic liver (EL) and finally the BM. Identifying the embryonic sites from which the adult pool of HSCs originates is crucial for understanding the mechanisms responsible for the generation of adult stem cells. Because HSCs always emerge in close physical association with endothelial cells (ECs), a common origin for the two cell types has been proposed (reviewed in Dzierzak and Speck, 2008; Cumano and Godin, 2007) . In the human embryo, the first hematopoietic cells (HCs) production in the embryo proper, first documented in bird (reviewed in Dieterlen-Lièvre, 1994) , then in mouse (reviewed in Dzierzak and Speck 2008; Mikkola and Orkin, 2006) and human (reviewed in Peault et al., 2002) . Even more obvious than in the yolk sac, intraembryonic HSCs were noted to arise in close physical association with the ventral endothelium of the dorsal aorta. In the human embryo, these cells were first detected at day 27, in the aortic endothelium as well as in the umbilical and vitelline arteries surface. They then expand rapidly to form clusters of several thousand cells at day 35 and disappear at day 40 (Tavian et al., 1996 and 1999) . These observations led to the proposal that ECs may give rise to HCs. Direct filiation of HCs from pre-existing endothelium was suggested by using lineage-marking experiments of ECs in the avian embryos (Jaffredo et al., 1998 and . In the mouse, candidate ECs sorted from the yolk sac and embryonic aorta-gonad-mesonephros (AGM) region formed blood cells in culture (Nishikawa et al., 1998b , Fraser et al., 2002 . Recently, several lineage-marking systems have been developed to directly approach the question of the temporal and spatial origin of blood cells in situ (Chen et al., 2009; Zovein et al., 2008; Li et al., 2006; De Bruijn et al., 2002; North et al., 2002) . All these approaches have suggested that discrete subsets of vascular ECs transiently exhibit blood-forming potential during vertebrate development. Recently a novel perspective to HSCs development came with the discovery that the human and murine placenta harbor a large pool of multipotential hematopoietic progenitors and stem cells, indicating that the placenta could play an important role in the establishment of hematopoiesis (Barcena et al., 2009; Robin et al., 2009; Mikkola et al., 2005 ; see also Ottersbach and Dzierzak; Mikkola, Dieterlen-Lièvre et al., in this issue) . This process of HSCs emergence in the placenta is also intimately associated with large vessels (Rhodes et al., 2008) and therefore do highlight the role of vascular ECs in the generation of HSCs in vertebrates not only in the AGM, the umbilical and vitelline arteries but also in the placenta. Several reports suggest that intaembryonic HSCs are generated by other structures, called subaortic patches (SAPs), located below the aortic floor, and which appear as another supportive niche for the intraembryonic HSCs generation in the paraaortic splanchnopleura (PSp)/AGM region (Bertrand et al., 2005; Manaia et al., 2000) . At the end, it is possible that both origins exist (Zovein et al., 2008) , and that depending on the site of production, HSCs might be endowed with different properties in adult life.
Primitive and definitive human hematopoiesis originate from the embryonic endothelium
To address whether vascular ECs in the human yolk sac, AGM, EL and fetal BM are endowed with hematopoietic ability, we sorted endothelial and hematopoietic progenitor cells from these blood-forming tissues and tested their hematopoietic potential in vitro. At these early stages of development, most surface markers expressed on HCs are also present on ECs, with the exception of CD45, a hematopoietic-specific marker. To discriminate between these two cell lineages, we sorted endothelial and hematopoietic progenitor cells on their common expression of CD34 and CD31, and absence of CD45 at the surface of ECs. When cultured in the presence of MS-5, a mouse BM stromal cell line that supports the multilineage, long-term development of human HSCs, the CD34 + CD31 + CD45 -embryonic and fetal ECs were able to produce blood cells. This was the case for ECs sorted from human yolk sac and AGM region but also, less expectedly, from EL and fetal BM . However the frequency of hemogenic ECs in the EL and fetal BM remained much lower than in the yolk sac and in the aorta region . Finally, it must be emphasized that no hematopoietic potential was ever detected among CD34 + CD31 + CD45 -sorted cells from non-hematopoietic tissues such as the heart, fetal aorta, pancreas, lung or umbilical cord . Taken together our results demonstrated the existence of a blood-forming vascular endothelium in the human embryo and fetus. This hemogenic endothelium appears to be a characteristic of early sites of HCs emergence such as yolk sac and embryonic aorta, and could be at the origin of both primitive and definitive hematopoiesis. Surprisingly presence of hemogenic ECs, albeit at a lower frequency, was also observed in the EL and the fetal BM, where no HCs are supposed to emerge intrinsically. The mouse liver rudiment does not support hematopoiesis when organ-cultured apart from the rest of the embryo, which led to assume that hepatic hematopoiesis originates from extrinsic circulating progenitors (Johnson and Moore, 1975) . Similarly, using chicken embryo parabionts (Metcalf and Moore, 1971) and quail/chicken embryonic chimeras (Le Douarin et al., 1975) , it was shown that medullary hematopoiesis occurred via blood-borne stem cells. Direct migration of beforehand-labelled fetal liver HCs to the BM was suggested (Clapp et al., 1995) . Yet, these results cannot totally rule out the participation of the liver and BM endothelial compartment to hematopoietic production, nor do they exclude the possibility that the liver and BM rudiments are colonized by angio-hematopoietic or pluripotent mesodermal stem cells that may be ancestors of hemogenic ECs or by hemogenic ECs themselves. Another possibility is that hemogenic precursors contained within EL and fetal BM CD34 + CD31 + CD45 -cell populations could strictly correspond to hematopoietic precursors, which is only possible if we admit that commitment to HCs arise before CD45 expression by these cells. Indeed, previous studies in human and murine ES models demonstrated that during hematopoietic development CD41 is expressed before CD45 (Eilken et al., 2009; Lancrin et al., 2009; Mikkola et al., 2003; Vodyanik et al., 2006) . Then, despite the fact that they are CD45 -, the CD34 + CD31 + CD45 -cells that we assimilated as ECs could correspond to already committed HCs.
Hemogenic endothelium in the human embryo is derived from an earlier subaortic mesenchymal population
We addressed the question of the origin of hemogenic ECs in the human embryo. Semi-thin sections through the aorta at hematopoietic stages revealed that ECs are profoundly disorganized, or even not present underneath intraaortic hematopoietic cell clusters (Tavian et al., 1999) . This indicates a possible circulation between cells lining the aorta and those underneath, and that cluster-forming cells could originate from the mesenchyme underlying the aorta. Indeed aortic hemogenic ECs may derive from angio-hematopoietic or even pluripotent mesodermal progenitors that could migrate secondarily from the underlying mesoderm to the endothelium which lines the vessel and forms an interface between blood and the rest of the embryo. In agreement with this assumption, we showed that CD34 + CD31 + CD45 -ECs isolated in the aortic region between day 23 to 26 did not display any hematopoietic potential, and that the earliest signs of aortic hematopoiesis were detected from day 27 . Conversely similar experiments performed on the PSp/ AGM of the pre-27-day embryo have demonstrated that the blood-forming activity was confined within non-endothelial, CD34 -CD31 -CD45 -cells (Zambidis et al., 2006) . This indicates that blood-forming potential is not imprinted in AGM ECs but is rather acquired upon colonization of the ventral wall of the aorta by a population of angiohematopoietic or pluripotent stem cells shortly before the 27 th day of development (rewiewed by Tavian et al. in this issue) . These progenitors, already present in the PSp during the third week of development could be at the origin of hemogenic ECs which in turn could give rise to aortic HSCs. Interestingly, we were not able to detect a blood-forming activity within non-endothelial, CD34 -CD31 -CD45 -cells sorted from the embryonic aorta in the post-27-day embryo, when HSCs have already emerged in the AGM region (Oberlin et al., unpublished observations) , which indicates that later subaortic mesenchymal cells fail to produce HCs in vitro. Thus, only the early and transient PSp/AGM mesenchymal population that gives rise to AGM aortic hemogenic endothelium has the capacity to produce HSCs progeny, and appears to do so through an endothelial intermediate. This results correlates with recent studies of aortic floor formation in both avian and murine systems (Wiegreffe et al., 2009 and Pouget et al., 2008 and Wasteson et al., 2008 ; see also Jaffredo et al., this issue) showing that the mesenchymal floor of the AGM region is transiently formed by a population derived from the lateral plate mesoderm and capable of contribution to the aortic endothelium, then replaced by a second population derived from sclerotomal mesoderm, that migrates from the dorsal and lateral walls to the ventral side of the aorta.
Seeking for the endothelial to hematopoietic cell transition in the human embryonic aorta
We reported above that angio-hematopoietic or pluripotent mesodermal stem cells, already present in the PSp during the third week of development could be at the origin of hemogenic ECs which could in turn give rise to aortic HSCs. In order to better elucidate the transition between the hemogenic endothelium and the hematopoietic clusters we performed immuno-histological localization of ECs and HCs in the human AGM region with CD45, CD34 and VE-cadherin, a specific marker for ECs (Lampugnani . VE-cadherin also recognizes cells in the mesenchyme underneath aorta. Sections were observed with a Nikon Eclipse E800 microscope equipped with Optigrid for confocal acquisition. Images were processed using Photoshop 7.0 software (Adobe Systems, San Jose, CA). Abbreviations: nt, neural tube; nc, notochord; g, gonad; mn, mesonephros; da, dorsal aorta; sam, subaortic mesenchyme. et al., 1992) . Immuno-histochemistry on a 5-week-old human embryo confirmed that all vascular ECs lining the dorsal aorta express CD34 (Fig. 1 A,B) while CD45 expression was restricted to HCs disseminated in very low numbers within tissues, albeit somehow more densely in the subaortic mesenchyme (Fig. 1C) . None of these HCs scattered throughout embryonic tissues was ever found positive for CD34 expression (Fig. 1A and 1B) . CD45 + cells were very rarely detected inside blood vessels, which contained almost exclusively erythrocytes (Fig. 1C) . In contrast, HCs clustered on the ventral endothelium of aorta were all CD34 + CD45 + (Fig. 1A, 1B and 1C) , as documented before Tavian et al., 1999 and 1996) . As expected, the VE-cadherin adhesion molecule was present at the luminal aspect of vascular endothelium, but also on HCs clumped on the vessel floor, yet to a lesser extend (Fig. 1D ). This immuno-localization confirmed that all vascular ECs in the human embryo express CD34 and VEcadherin and can be readily distinguished from hematopoietic progenitors by the absence of CD45 expression. Immuno-labellings also show for the first time that HCs present in the human embryonic aorta are co-expressing the endothelial specific marker VE-cadherin and the pan-leukocyte antigen CD45. This is in agreement with studies in the mouse embryo showing that HSCs that appear in the YS and the AGM are bearing such a dual B C D A hemato-endothelial phenotype (Taoudi et al., 2005 and Fraser et al., 2003; North et al., 2002) . Thus, as in the mouse embryo, the first founder HSCs of human embryo seem to maintain endothelial feature while acquiring hematopoietic traits, which confirms that definitive hematopoiesis originates from the embryonic endothelium.
Progressive divergence of definitive hematopoietic stem cells from the endothelial compartment in the human embryonic liver
Since HCs produced in the embryonic aorta are likely to seed the EL we hypothesized that cells expressing both endothelial and hematopoietic traits could also be detected in the human EL, as it has already be demonstrated in the mouse fetal liver (Kim et al., 2005; Taoudi et al., 2005) . As expected, we found that some of HCs present in the EL co-expressed the pan-leukocyte antigen CD45 and the endothelial specific marker VE-cadherin (Fig. 2) . Indeed, VE-cadherin and CD45 expressions were predominantly mutually exclusive except in a very rare double-positive (DP) cell population constituting less than 0.5% of the total liver population (Fig. 2) . We also observed that this population decreased throughout EL development and was completely lost at the fetal liver stage, suggesting that as hematopoietic development progresses VE-cadherin was downregulated, and that the DP cells could give rise to VE-cadherin -HCs (Oberlin et al., submitted) . Extensive flow cytometry analysis, used to better characterize the DP VEcadherin + CD45 + cell subset, revealed significant differences between the DP and the EC fractions (Table 1) . Whereas ECs strongly expressed endothelial markers, the DP cells did not, or expressed them only on few cells. As expected, the HC fraction was either negative for these markers, or expressed them on a very low number of cells (Table 1) . Conversely, analysis of HSC specific cell-surface markers demonstrated that the majority of the DP cells expressed these markers, whereas only few cells of the HC population did (Table 1) . Flow cytometry analysis also revealed that the DP fraction had a cell surface phenotype that included the expression of early hematopoietic differentiation markers (Table 1) . Another phenotypic feature of the DP population was the absence of cell-surface markers associated with hematopoietic lineage differentiation (Oberlin et al., submitted) . Thus our phenotypic analysis reveals higher similarity between DP cells and HCs than between DP cells and ECs, and strongly suggests that if the DP cell population is an intermediary population between the endothelial and the hematopoietic populations, it seems to have already diverged from the endothelial compartment and to be committed to the hematopoietic compartment. To determine precisely which type of HCs (hematopoietic progenitors or stem cells) is contained in the DP population, we sorted a subpopulation of 34DP cells, co-expressing VE-cadherin, CD45 and CD34 (the majority of the DP cells expresses CD34 -see Table 1 ) from the EL, and evaluated its hematopoietic potential in vitro and in vivo. In all cases, this potential was compared to that of the subpopulation of 34HCs expressing CD45 and CD34 but lacking VE-cadherin. Hematopoietic assays clearly demonstrated functional differences between the two cell populations. First, all the colonies produced by 34DP cells in colony-forming cells assays were typical high proliferation potential (HPP)-colony- forming units (CFUs) while no HPP-CFUs were produced by the 34HC population (Fig. 3A) . Likewise, only 34DP cells were able to produce secondary hematopoietic colonies. Second, the kinetic of proliferation in long-term culture assays were obviously distinct in the two populations. 34DP cells produced HCs with a delay compared to the 34HCs (Fig. 3B) and extended long-term hematopoiesis only occurred in wells seeded with the 34DP population. Third, the repopulating ability of the 34DP cells in NOD/ SCID mice was much better than that of the 34HCs, since all transplanted mice were reconstituted when as few as 5 000 34DP cells were transplanted, whereas no mice were reconstituted with 5 000 34HCs. Even when ten times more 34HCs were transplanted, only one mouse out of 6 was reconstituted, testifying the high reconstitution potential of the 34DP cells (Oberlin et al., submitted) . We also tested the hematopoietic capacities of the EC fraction and confirmed that EL ECs were no longer, or weakly capable of producing HCs in vitro and in vivo (Oberlin et al., submitted) . Thus, our in vitro hematopoietic cell assay and in vivo long-term transplantation experiments in NOD/SCID mice demonstrated that in EL hematopoietic differentiation was more or less exclusively associated with the 34DP and 34HC fractions, and that the 34DP population was endowed with higher self renewal, proliferative and reconstitution potentials than its 34HC counterpart. Thus 34DP cells could be enriched for primitive hematopoietic progenitors and stem cells compared to 34HCs, and could represent an earlier stage of development. The more primitive 34DP population could represent an intermediary population between the hemogenic ECs that we previously identified in the human embryo and fetus, and the more advanced 34HC population. The 34DP population could diverge from hemogenic ECs prior to the onset of definitive hematopoiesis, loosing endothelial markers expression as they gain hematopoietic markers expression.
Fate mapping of endothelial cells during mouse development: VE-cadherin to trace the origin of hematopoietic cells
Unravelling the origins of early hematopoiesis through analysis of human embryos and fetus is difficult, both practically and ethically. Although such studies have yielded valuable information (Zambidis et al., 2006) most data on ontogeny of vertebrate blood formation have been gained through analysis of model organisms including mice. To prove the endothelial origin of murine HSCs few groups engineered transgenic mice to trace the ECs descent, taking advantage of the Cre/lox system. This model requires two transgenic lines: one with CRE recombinase under the control of the promoter of a gene of interest (gene specific for endothelial lineage, for instance), and a second line that contains a conditional reporter gene (lacZ or GFP), "floxed" (ie expression 
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et al., submitted): an enhancer region is present in this first intron, which augments the activity of the 2.5 kbp 5' promoter region while maintaining endothelial specificity. This combination is so far the most optimum for ECs-specific gene expression that can also express gene in VE-cad + progenitors of HCs, but not in fully committed HCs (Hisatsune et al., 2005) .
In all the models, mating with Rosa26R LacZ or GFP mice demonstrated that β-gal activity or GFP labelling could be detected throughout the vasculature in double transgenic VECR embryos, indicating that the VE-cadherin promoter was correctly activated in cells responsible for developmental vessel formation, as expected. Of note, as soon as E10.5 we observed a large number of fetal liver cells with LacZ activity (Fig. 4B) . At this stage, a high activity is also detected in the umbilical artery (Fig. 4B) . In the placenta, at E11.5 and E12.5, when the highest number of HSCs can be detected (Mikkola et al., 2005) , we found that LacZ activity resides mainly in the big vessels present in the chorionic plate rather than in the labyrinth (Fig. 4C ). In addition, using the fluorescent substrate fluorescein-di-β-D-galactopyranoside (FDG) of β-gal, we could show that not only the VE-cadherin lineage labeled the AGM, yolk sac, placenta and fetal liver CD45 + hematopoietic populations, but also the CD34 + c-kit hi population, enriched of reporter gene is dependent on the excision of a stuffer sequence flanked by two lox sequences), under the control of an ubiquitous promoter. Classically, the Rosa26R reporter mouse line established by Soriano (Soriano, 1999 ) (reporter gene = lacZ or GFP or YFP) is used. In the double transgenic mice, the first cells which express the gene of interest will be permanently labelled with the reporter gene, and this will allow following their filiations.
All the models recently developed used the promoter element of the VE-cadherin gene (CD144 or cadherin 5), a specific marker for adult ECs, which is essential for endothelial cell-cell interaction (Dejana, 2004) . VE-cadherin is required in vivo in the postnatal vasculature to maintain ECs integrity and barrier function (Corada et al., 1999) . Absence of VE-cadherin by homologous recombination leads to embryonic lethality by day E9.5 due to severe vasculogenic defects in the yolk sac and embryo (Carmeliet et al., 1999; Gory-Faure et al., 1999) . Using in vitro differentiation of murine ES cells, Nishikawa et al. showed that FLK1 + VE-cad + CD45 -cells represent a population at the diverging point of hematopoietic and endothelial cell lineages (Nishikawa et al., 1998a) . The same team demonstrated that VE-cad + CD45 -ECs isolated from E9.5 embryos and yolk sac are able to generate HCs in vitro (Nishikawa et al., 1998b , Fraser et al., 2003 . VE-cadherin is also expressed by HSCs emerging in hematopoietic sites (AGM E11.5 and YS E12.5) (Taoudi et al., 2005 and Fraser et al., 2003; North et al., 2002) . This expression disappears after liver colonization (Kim et al., 2005; Taoudi et al., 2005) .
Three groups engineered a VE-cad CRE transgenic mouse, using the 2.5 kb 5' promoter element of the VE-cadherin gene, described by Gory et al. (Kogata et al., 2006; Alva et al., 2006; Zovein et al., 2008; Chen et al., 2009) . In addition to the constitutive VE-cad/CRE transgene, M.Luisa Iruela-Arispe's team designed a conditional VE-cad/ CRE ER T2 transgenic mouse, allowing inducible recombination in the endothelium after tamoxifen injection . Based on data from Hisatsune et al. (Hisatsune et al., 2005) , our group designed another VE-cad transgenic mouse, with the Cre recombinase under the control of both the 5' promoter flanking region and the 5' half of the first intron of VE-cadherin gene (Fig. 4A and Petit-Cocault B C A in HSCs (Fig. 5A) .
More variations were observed in adult mice: while Kogata et al. (Kogata et al., 2006) and Hisatsune et al. (Hisatsune et al., 2005) found that VE-cadherin promoter alone becomes less active after birth, as originally described by , and that a good expression in adults requires the enhancer element, Iruela-Arispe's ) and Speck's (Chen et al., 2009 ) teams found a very good expression all over mice time life. Indeed, our transgenic model allowed a good expression in all the adult tissues that we analyzed (Petit-Cocault et al., submitted) .
When double transgenic VECR mice were used to analyze the adult hematopoietic descent of VE-cadherin ECs, a majority of adult HCs were found to originate from a VE-cadherin expressing ancestor (20 to 90% of adult BM) (Fig. 5B) . Moreover, using FDG, we showed that half of the lineage negative (lin -) Sca1 + c-kit + (LSK) HSC population of adult BM was FDG + (38.1% ± 5%, range 30.4-47.7%), and therefore derived from a VE-cadherin ancestor (Fig.  5B) . The FDG + LSK population presented the classical in vitro properties of HSCs with the same frequency of LTC-IC than FDG -LSK cells (0.0018±0.001 versus 0.0020±0.001, respectively). When injected in lethally irradiated Ly5.1 mice, FDG + LSK cells showed long-term hematopoietic reconstitution ability (Fig. 6) , contributing to all lineages of BM, spleen, thymus and blood (PetitCocault et al., submitted) . In addition, when BM cells from reconstituted animals were injected to secondary irradiated Ly5.1 recipients in order to test self-renewal ability, a significant number of Ly5.2 + FDG + cells (10 to 61%) were still detected in the BM of reconstituted mice more than 4 months after injection (Fig. 6) . Our results strongly suggest that VE-cadherin embryonic endothelial population is at the origin not only of the majority of adult HCs, but also of definitive BM resident HSCs. This conclusion is corroborated by the tamoxifen-inducible VE-cadherin Cre line developed (Zovein et al., 2008) . Using a SMVα CRE and a myocardin CRE line which allowed them to trace mesenchyme separately, these authors further demonstrated that the endothelium is responsible for HSC emergence in the AGM and that it is derived from a transient mesenchymal population.
Conclusion
In conclusion, our observations confirm that at least part of emerging HCs in the human and murine embryos arise via an endothelium-like developmental intermediate. Our human studies clearly show that during human development, the hematopoietic potential seems to progressively shift from the endothelial to the hematopoietic compartment. Indeed, in the human EL, hematopoietic differentiation was associated more or less exclusively with the 34DP and 34HC fractions, whereas during earlier human embryo development such activity was also clearly associated with the endothelial fraction in the yolk sac and the AGM region. Furthermore, our mouse transgenic model clearly demonstrated that a majority, if not all of the adult BM HSCs are derived from a VEcadherin expressing ancestor. Thus both our human and murine approaches have unravelled a precise hematopoietic hierarchy and demonstrated that the two mammals display identical schemes concerning the development of their hematopoietic systems.
